Target intelligence / Profile preview

RNA, U6 small nuclear 622, pseudogene (RNU6-622P)

Target
RNU6-622P
Molecular classification
Pseudogene, small nuclear RNA (snRNA) pseudogene, miscRNA (miscellaneous noncoding RNA)
01

Overview

RNU6-622P represents a pseudogene belonging to the U6 small nuclear RNA gene family. U6 snRNA is a highly conserved, essential component of spliceosomal snRNPs in eukaryotic cells, forming part of the core machinery for pre-mRNA intron removal[1][3]. Numerous pseudogenes derived from U6 snRNA exist throughout vertebrate genomes, likely reflecting the evolutionary importance of the parent gene[1][4]. Such pseudogenes generally do not encode functional products or participate in canonical RNA splicing, and their biological roles remain limited or secondary. RNU6-622P is not an established therapeutic target, receptor, or protein of interest in drug discovery or clinical medicine[2].\n\nIf you seek structured information for a functional target, refer to “U6 small nuclear RNA” (U6 snRNA), not the RNU6-622P pseudogene.

Other names
RNU6-622PRNA, U6 small nuclear 622, pseudogeneU6 snRNA pseudogene
02

Mechanism of action

None applicable, as pseudogenes are not pharmacologically targeted.

03

Biological functions

None directly for the pseudogene.
04

Disease associations

None direct or established for RNU6 pseudogenes.
05

Safety considerations

None specific; not a therapeutic or diagnostic entity.
06

Interacting drugs

None
07

Biomarkers

None established for RNU6-622P.

Beyond the preview

Go deeper on RNA, U6 small nuclear 622, pseudogene (RNU6-622P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 622, pseudogene (RNU6-622P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call